1University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK
2University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK
3Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA USA
4Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands
5Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands
6The Netherlands Cancer Institute—Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands
7Veneto Institute of Oncology IOV—IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy
8Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada
9University of Toronto, Department of Molecular Genetics, Toronto, ON Canada
10University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA
11N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus
12‘Agii Anargiri’ Cancer Hospital, Athens, Greece
13University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX USA
14Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden
15Vall d’Hebron Institute of Oncology, Hereditary cancer Genetics Group, Barcelona, Spain
16University Hospital of Vall d’Hebron, Department of Medical Oncology, Barcelona, Spain
17Rutgers Cancer Institute of New Jersey, Cancer Prevention and Control Program, New Brunswick, NJ USA
18Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland
19University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland
20University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany
21Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA
22Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain
23Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain
24Ufa Federal Research Centre of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia
25Princess Margaret Hospital, Division of Gynecologic Oncology, University Health Network, Toronto, ON Canada
26Haukeland University Hospital, Department of Obstetrics and Gynecology, Bergen, Norway
27University of Bergen, Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, Bergen, Norway
28National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA
29Hannover Medical School, Department of Radiation Oncology, Hannover, Germany
30Hannover Medical School, Gynaecology Research Unit, Hannover, Germany
31IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy
32Lund University and Skåne University Hospital, Department of Oncology, Lund, Sweden
33Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
34Maria Sklodowska-Curie National Research Institute of Oncology, Department of Pathology and Laboratory Diagnostics, Warsaw, Poland
35University of Helsinki, Department of Pathology, Helsinki University Hospital, Helsinki, Finland
36Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT USA
37University Hospital, SOD Genetica Molecolare, Pisa, Italy
38Peter MacCallum Cancer Center, Melbourne, VIC Australia
39The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia
40Roswell Park Cancer Institute, Cancer Pathology & Prevention, Division of Cancer Prevention and Population Sciences, Buffalo, NY USA
41Division of Human Genetics, The Ohio State University, Department of Internal Medicine, Columbus, OH USA
42German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany
43University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany
44National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA
45Tianjin Medical University Cancer Institute and Hospital, Department of Epidemiology, Tianjin, China
46The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, NSW Australia
47Westmead Hospital, Department of Gynaecological Oncology, Sydney, NSW Australia
48Columbia University, Departments of Pediatrics and Medicine, New York, NY USA
49Ghent University, Centre for Medical Genetics, Gent, Belgium
50INSERM U830, Department of Tumour Biology, Paris, France
51Institut Curie, Paris, France
52Mines ParisTech, Fontainebleau, France
53Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany
54University of New Mexico, University of New Mexico Health Sciences Center, Albuquerque, NM USA
55Alberta Health Services, Department of Cancer Epidemiology and Prevention Research, Calgary, AB Canada
56Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA
57Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA USA
58Memorial Sloan Kettering Cancer Center, Gynecology Service, Department of Surgery, New York, NY USA
59Cambridge, Cambridge, UK
60CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Molecular Oncology Laboratory, Madrid, Spain
61NorthShore University Health System, Center for Medical Genetics, Evanston, IL USA
62The University of Chicago Pritzker School of Medicine, Chicago, IL USA
63Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands
64Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands
65Vall dHebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain
66University Hospital Vall dHebron, Clinical and Molecular Genetics Area, Barcelona, Spain
67Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA
68University of Utah, Huntsman Cancer Institute, Department of Population Health Sciences, Salt Lake City, UT USA
69University of Pennsylvania, Basser Center for BRCA, Abramson Cancer Center, Philadelphia, PA USA
70Ev. Kliniken Essen-Mitte (KEM), Department of Gynecology and Gynecologic Oncology, Essen, Germany
71Dr. Horst Schmidt Kliniken Wiesbaden, Department of Gynecology and Gynecologic Oncology, Wiesbaden, Germany
72Jena University Hospital—Friedrich Schiller University, Department of Gynaecology, Jena, Germany
73University of Southampton, Faculty of Medicine, Southampton, UK
74Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA
75Brigham and Women’s Hospital and Harvard Medical School, Channing Division of Network Medicine, Boston, MA USA
76University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany
77University of Leipzig, LIFE—Leipzig Research Centre for Civilization Diseases, Leipzig, Germany
78University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK
79St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, UK
80University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, Los Angeles, CA USA
81Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, London, UK
82Masaryk Memorial Cancer Institute, Department of Cancer Epidemiology and Genetics, Brno, Czech Republic
83Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel
84Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel
85Jonsson Comprehensive Cancer Centre, UCLA, Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Los Angeles, CA USA
86Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA
87University of Florence, Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, Medical Genetics Unit, Florence, Italy
88Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia
89The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, VIC Australia
90Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia
91University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS USA
92Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA USA
93National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA
94Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland
95QIMR Berghofer Medical Research Institute, Population Health Department, Brisbane, QLD Australia
96Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany
97University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA USA
98Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden
99German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany
100Rigshospitalet, Copenhagen University Hospital, Department of Clinical Genetics, Copenhagen, Denmark
101Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA USA
102University of Washington, Department of Epidemiology, Seattle, WA USA
103National University of Singapore and National University Health System, Saw Swee Hock School of Public Health, Singapore, Singapore
104National University Health System, Department of Surgery, Singapore, Singapore
105Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Berlin, Germany
106University of Texas MD Anderson Cancer Center, Department of Epidemiology, Houston, TX USA
107Danish Cancer Society Research Center, Department of Virus, Lifestyle and Genes, Copenhagen, Denmark
108University of Copenhagen, Molecular Unit, Department of Pathology, Herlev Hospital, Copenhagen, Denmark
109University of Copenhagen, Department of Gynaecology, Rigshospitalet, Copenhagen Denmark
110Roswell Park Cancer Institute, Center For Immunotherapy, Buffalo, NY USA
111BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia’s Ovarian Cancer Research (OVCARE) Program, Vancouver, BC Canada
112University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, BC Canada
113University of British Columbia, Department of Obstetrics and Gynecology, Vancouver, BC Canada
114BC Cancer Research Centre, Department of Molecular Oncology, Vancouver, BC Canada
115N.N. Petrov Institute of Oncology, St. Petersburg, Russia
116Coordinating center: The Netherlands Cancer Institute, The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Amsterdam, The Netherlands
117Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC USA
118Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland
119Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia
120Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius, Lithuania
121State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
122Landspitali University Hospital, Department of Oncology, Reykjavik, Iceland
123Stanford University School of Medicine, Department of Epidemiology & Population Health, Stanford, CA USA
124Stanford Cancer Institute, Stanford University School of Medicine, Department of Medicine, Division of Oncology, Stanford, CA USA
125The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK
126Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, Korea
127Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, Korea
128Seoul National University, Cancer Research Institute, Seoul, Korea
129University of California at Los Angeles, David Geffen School of Medicine, Department of Obstetrics and Gynecology, Los Angeles, CA USA
130UC Davis Medical Center, Department of Pathology and Laboratory Medicine, Sacramento, CA USA
131Medical University of South Carolina, Hollings Cancer Center, Charleston, SC USA
132Saint Petersburg State University, Saint Petersburg, Russia
133Sungkyunkwan University School of Medicine, Department of Obstetrics and Gynecology, Samsung Medical Center, Seoul, Korea
134City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA USA
135Cancer Genetics Centre, Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong
136The University of Hong Kong, Department of Surgery, Pok Fu Lam, Hong Kong
137Hong Kong Sanatorium and Hospital, Department of Surgery, Happy Valley, Hong Kong
138VIB Center for Cancer Biology, Leuven, Belgium
139University of Leuven, Laboratory for Translational Genetics, Department of Human Genetics, Leuven, Belgium
140Mayo Clinic, Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Rochester, MN USA
141ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Hereditary Cancer Program, Barcelona, Spain
142BC Cancer, Cancer Control Research, Vancouver, BC Canada
143Inserm U900, Genetic Epidemiology of Cancer team, Paris, France
144NYU Langone Medical Center, Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, New York, NY USA
145Genome Institute of Singapore, Human Genetics Division, Singapore, Singapore
146University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Clinical Cancer Genetics Program, Houston, TX USA
147Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
148Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Unit of Medical Genetics, Department of Medical Oncology and Hematology, Milan, Italy
149Duke University Hospital, Department of Surgery, Durham, NC USA
150University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, HI USA
151Aichi Cancer Center Research Institute, Division of Cancer Epidemiology and Prevention, Nagoya, Japan
152Nagoya University Graduate School of Medicine, Division of Cancer Epidemiology, Nagoya, Japan
153Samuel Lunenfeld Research Institute, Public Health Ontario, Toronto, ON Canada
154Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, UK
155University of Glasgow, Institute of Cancer Sciences, Glasgow, UK
156University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
157Roswell Park Cancer Institute, NRG Oncology, Statistics and Data Management Center, Buffalo, NY USA
158Roswell Park Cancer Institute, Division of Cancer Prevention and Control, Buffalo, NY USA
159Magee-Womens Research Institute and Hillman Cancer Center, Womens Cancer Research Center, Pittsburgh, PA USA
160University of Pittsburgh School of Medicine, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, Pittsburgh, PA USA
161Oregon Health & Science University, Department of Obstetrics and Gynecology, Portland, OR USA
162Oregon Health & Science University, Knight Cancer Institute, Portland, OR USA
163University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
164National Cancer Centre, Cancer Genetics Service, Singapore, Singapore
165Nanyang Technological University, Lee Kong Chian School of Medicine, Singapore, Singapore
166Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark
167Latvian Biomedical Research and Study Centre, Riga, Latvia
168Roswell Park Cancer Institute, Department of Gynecologic Oncology, Buffalo, NY USA
169Memorial Sloan Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA
170Memorial Sloan Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA
171National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary
172University Hospitals Leuven, Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, Leuven, Belgium
173The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA
174Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY USA
175Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain
176QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia
177Aalborg University Hospital, Molecular Diagnostics, Aalborg, Denmark
178Aalborg University Hospital, Clinical Cancer Research Center, Aalborg, Denmark
179Aalborg University, Department of Clinical Medicine, Aalborg, Denmark
180Portuguese Oncology Institute, Department of Genetics, Porto, Portugal
181Moffitt Cancer Center, Department of Cancer Epidemiology, Tampa, FL USA
182IFOM—the FIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy
183Bashkir State University, Department of Genetics and Fundamental Medicine, Ufa, Russia
184Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy
185Karolinska Institutet, Clinical Genetics, Stockholm, Sweden
186Duke University Hospital, Department of Gynecologic Oncology, Durham, NC USA
187Yale School of Public Health, Chronic Disease Epidemiology, New Haven, CT USA
188Fox Chase Cancer Center, Population Studies Facility, Philadelphia, PA USA
189National Institute of Environmental Health Sciences, NIH, Epidemiology Branch, Research Triangle Park, NC USA
190Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain
191Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain
192Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Genomics Center, Québec City, QC Canada
193Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany
194Hebei Medical University, Fourth Hospital, Department of Obstetrics and Gynaecology, Shijiazhuang, China
195Icahn School of Medicine at Mount Sinai, Department of Population Health Science and Policy, New York, NY USA
196Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, NY USA
197Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Genomic Center, Québec City, QC Canada
198Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria
199University of Cambridge, Department of Public Health and Primary Care, Cambridge, UK
200The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia
201Royal Alexandra Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Edmonton, AB Canada
202Institut Curie, Service de Génétique, Paris, France
203Université Paris Descartes, Paris, France
204University of South Florida, Epidemiology Center, College of Medicine, Tampa, FL USA
205The Institute of Cancer Research, Division of Breast Cancer Research, London, UK
206University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal
207Cancer Research Malaysia, Breast Cancer Research Programme, Subang Jaya, Selangor Malaysia
208University of Malaya, Department of Surgery, Faculty of Medicine, Kuala Lumpur, Malaysia
209Brigham and Women’s Hospital and Harvard Medical School, Obstetrics and Gynecology Epidemiology Center, Boston, MA USA
210Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY USA
211Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA USA
212McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada
213University of Cambridge, Department of Medical Genetics, Cambridge, UK
214Dartmouth College, Geisel School of Medicine, Hanover, NH USA
215The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH USA
216Pontificia Universidad Javeriana, Institute of Human Genetics, Bogota, Colombia
217University of Oxford, Cancer Epidemiology Unit, Oxford, UK
218Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA USA
219University Medical Center Groningen, University Groningen, Department of Genetics, Groningen, The Netherlands
220University of Pretoria, Department of Genetics, Arcadia, South Africa
221Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
222Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain
223Vanderbilt University Medical Center, Division of Quantitative Sciences, Department of Obstetrics and Gynecology, Department of Biomedical Sciences, Women’s Health Research, Nashville, TN USA
224Duke Cancer Institute, Cancer Control and Population Sciences, Durham, NC USA
225Duke University Hospital, Department of Community and Family Medicine, Durham, NC USA
226National Institute of Environmental Health Sciences, NIH, Biostatistics and Computational Biology Branch, Research Triangle Park, NC USA
227City of Hope, Clinical Cancer Genomics, Duarte, CA USA
228Fred Hutchinson Cancer Research Center, Seattle, WA USA
229Stanford University School of Medicine, Department of Biomedical Data Science, Stanford, CA USA
230Uppsala University, Department of Surgical Sciences, Uppsala, Sweden
231University of Malaya, Department of Obstetrics and Gynaecology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
232Hebei Medical University, Fourth Hospital, Department of Molecular Biology, Shijiazhuang, China
233National Centre for Scientific Research ‘Demokritos’, Molecular Diagnostics Laboratory, INRASTES, Athens, Greece
234Institute of Biochemistry and Experimental Oncology, First Faculty od Medicine, Charles University, Prague, Czech Republic
235Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Centre, Department of Obstetrics and Gynecology, Los Angeles, CA USA
236Royal Pass Road, Tampa, FL USA
237University of NSW Sydney, School of Women’s and Children’s Health, Faculty of Medicine, Sydney, NSW Australia
238University of NSW Sydney, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, NSW Australia
239University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI USA
240University of Southern California Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA USA
241Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, MN USA
242Emory University, Department of Epidemiology, Rollins School of Public Health, Atlanta, GA USA